Emergent Biosolutions, Inc. (EBS) is a publicly traded Healthcare sector company. As of May 21, 2026, EBS trades at $8.18 with a market cap of $419.48M and a P/E ratio of -58.21. EBS moved +1.30% today. Year to date, EBS is -36.58%; over the trailing twelve months it is +17.44%. Its 52-week range spans $4.02 to $14.06. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces EBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Emergent Biosolutions, Inc. (EBS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EBS moved +1.30% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $8.18 |
| Market Cap | $419.48M |
| P/E Ratio | -58.21 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.06 |
| 52-Week Low | $4.02 |
| Volume | 458 |
| Avg Volume | 0 |
| Revenue (TTM) | $676.80M |
| Net Income | $-8.60M |
| Gross Margin | 54.24% |
1 analysts cover EBS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.